260
Participants
Start Date
December 13, 2022
Primary Completion Date
February 28, 2025
Study Completion Date
November 30, 2025
Sacubitril-valsartan
level 1-24 / 26mg 2 times a day, level 2-49 / 51mg 2 times a day, level 3-97 / 103mg 2 times aday
Enalapril
level 1-2.5 mg twice a day, level 2-5 mg twice a day, level 3-10 mg twice a day
placebo
placebo matching for 24 / 26mg, 49 / 51mg, 97 / 103mg 2 of sacubitril/valsartan
Placebo
placebo matching for 2.5 mg, 5 mg, 10 mg of enalapril
NOT_YET_RECRUITING
Medical University of Bialystok Clinical Hospital, Bialystok
NOT_YET_RECRUITING
University Clinical Centre in Gdańsk, Gdansk
NOT_YET_RECRUITING
University Clinical Hospital in Opole, Opole
RECRUITING
University Hospital in Poznan, Poznan
NOT_YET_RECRUITING
Specialist Hospital in Zabrze, Zabrze
Collaborators (1)
Medical Research Agency, Poland
OTHER_GOV
Medical University of Bialystok
OTHER
University of Opole
OTHER
Medical University of Gdansk
OTHER
Medical University of Silesia
OTHER
Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań
OTHER